PRFX 0.98 (-10.91%)
IL0011651580Drug ManufacturersDrug Manufacturers - Specialty & Generic

PainReform (PRFX) Competitor Comparison

We are evaluating the key criteria listed to compare PainReform (PRFX) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 10 years - PRFX ranking 0 / 55

These are the competitors of PainReform in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 10 years
1. Theratechnologies THTX
1.17K
2. Alimera Sciences ALIM
131.23
3. Evolus EOLS
51.67
4. Ironwood Pharmaceuticals IRWD
27.59
5. Phibro Animal Health PAHC
18.81
6. Eagle Pharmaceuticals EGRX
13.68
7. PetIQ PETQ
8.14
8. Regencell Bioscience Holdings RGC
7.87
9. Vifor Pharma G2AB.F
7.23
10. Alvotech ALVO
7
11. Linc LNC
6.35
12. Ayr Wellness 3KJB.F
5.24
13. Curaleaf Holdings CURLF
5.03
14. Kolinpharma KIP.MI
4.84
15. Emergent BioSolutions EBS
4.55
16. Cumberland Pharmaceuticals CPIX
4.19
17. Taro Pharmaceutical Industries TARO
3.8
18. Societal CDMO SCTL
3.72
19. Pacira BioSciences PCRX
3.68
20. Elanco Animal Health ELAN
3.44
21. Organogenesis Holdings ORGO
3.33
22. Procaps Group PROC
3.16
23. Avadel Pharmaceuticals AVDL
3.07
24. Cronos Group CRON
2.92
25. Green Thumb Industries R9U2.F
2.62
26. Embecta EMBC
2.5
27. Tilray Brands TLRY
2.47
28. Amneal Pharmaceuticals AMRX
2.38
29. Perrigo PRGO
2.36
30. Teva Pharmaceutical Industries TEVA
2.34
31. Neoleukin Therapeutics NLTX
2.29
32. Journey Medical DERM
2.28
33. Kamada KMDA
2.18
34. Catalent CTLT
2.03
35. Clever Leaves Holdings CLVR
1.98
36. Jupiter Wellness JUPW
1.84
37. Ascend Wellness Holdings AAWH
1.81
38. Flora Growth FLGC
1.8
39. Bausch Health Companies BHC
1.79
40. Alpha Teknova TKNO
1.78
41. Biofrontera BFRI
1.73
42. OptiNose OPTN
1.73
43. Solid Biosciences SLDB
1.68
44. Relmada Therapeutics RLMD
1.68
45. Universe Pharmaceuticals UPC
1.66
46. Zynerba Pharmaceuticals ZYNE
1.63
47. SCYNEXIS SCYX
1.56
48. Supernus Pharmaceuticals SUPN
1.53
49. Harrow Health HROW
1.49
50. ANI Pharmaceuticals ANIP
1.38
51. MedAvail Holdings MDVL
1.34
52. Zoetis ZTS
0.83
53. ProPhase Labs PRPH
0.78
54. Collegium Pharmaceutical COLL
0.7
55. Amphastar Pharmaceuticals AMPH
0.58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.